Viremia and Immunogenicity in Nonhuman Primates of a Tetravalent Yellow Fever–Dengue Chimeric Vaccine: Genetic Reconstructions, Dose Adjustment, and Antibody Responses against Wild-type Dengue Virus Isolates
- 1 June 2002
- Vol. 298 (1) , 146-159
- https://doi.org/10.1006/viro.2002.1462
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Phenotypic and Molecular Analyses of Yellow Fever 17DD Vaccine Viruses Associated with Serious Adverse Events in BrazilVirology, 2001
- Construction, Safety, and Immunogenicity in Nonhuman Primates of a Chimeric Yellow Fever-Dengue Virus Tetravalent VaccineJournal of Virology, 2001
- Recombinant Chimeric Yellow Fever-Dengue Type 2 Virus Is Immunogenic and Protective in Nonhuman PrimatesJournal of Virology, 2000
- Type-3 dengue viruses responsible for the dengue epidemic in Malaysia during 1993-1994.The American Journal of Tropical Medicine and Hygiene, 1999
- Immunogenicity, Genetic Stability, and Protective Efficacy of a Recombinant, Chimeric Yellow Fever-Japanese Encephalitis Virus (ChimeriVax-JE) as a Live, Attenuated Vaccine Candidate against Japanese EncephalitisVirology, 1999
- Identification of a major determinant of mouse neurovirulence of dengue virus type 2 using stably cloned genomic-length cDNA.Journal of General Virology, 1998
- Molecular evolution and phylogeny of dengue-4 viruses.Journal of General Virology, 1997
- Molecular epidemiology of dengue-1 and dengue-4 virusesJournal of General Virology, 1995
- Phylogenetic Relationships of Dengue-2 VirusesVirology, 1993
- A Prospective Study of Dengue Infections in BangkokThe American Journal of Tropical Medicine and Hygiene, 1988